Karen Coe, 59, who has type 2 diabetes, says she was prescribed a GLP-1 medication to help her lose weight and get her ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an ...

(InvestigateTV) — Injectable drugs for weight loss are touted as game-changers, but the results can come at a high cost. Plus ...

IPL is passé, and Lok Sabha elections no longer carry the same thrill. A new battle is brewing in India, and is ready to take ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their GLP-1 products. Lilly markets its dual GIP and GLP-1 receptor agonist, ...

Eli Lilly says Indianapolis-based Premier Weight Loss is cracking open auto-injector pens containing its blockbuster drug and ...

Think you're using real Ozempic? Think again. Fake versions are everywhere—dangerous, unregulated, and often mislabeled.

Genetics or hormonal changes can pose challenges for losing weight, as you may know firsthand. Like many others struggling to ...